Dr. Gerardo Colon-Otero, MD

Dr. Colon-Otero practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Colon-Otero's NPI, 1598754228, was assigned on October 15, 2005. Dr. Colon-Otero graduated from University of Puerto Rico, Medical Sciences Campus in 1979. Dr. Colon-Otero holds Florida license ME48439.

Dr. Colon-Otero's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Colon-Otero's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Colon-Otero to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Colon-Otero practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Colon-Otero's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Colon-Otero is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Colon-Otero's licenses on file in 5 states: Florida, Arizona, Minnesota, Kentucky and Georgia.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, fluid and electrolyte imbalances, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Colon-Otero treats.

CMS data shows 94,683 Medicare services from Dr. Colon-Otero across 61 procedure codes in 2024, for 994 Medicare patients. Medicare paid $1,569,896 for them. Every service was in an office.

CMS counts 994 Medicare patients who saw Dr. Colon-Otero in 2024. The largest group is 65 to 74, with 472 patients. 73% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Colon-Otero's median patient age at 64, with 78% women.

In 2024, Dr. Colon-Otero wrote 739 Medicare Part D claims for 126 patients. 79% of them were for generic drugs. CMS names the drug for 460 of them, across 19 drugs with 11 or more claims each, at $220,311 in total drug cost. In 2023, CMS named 311 claims across 14 drugs.

Dr. Colon-Otero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Colon-Otero as offering telehealth.

Dmand AI links 78 papers to Dr. Colon-Otero, published from 2002 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Breast Neoplasms. Dr. Colon-Otero has published most often in Cancer. Dr. Colon-Otero's most frequent co-authors are Edith Perez, MD, Alvaro Moreno-Aspitia, MD and David Menke, MD.

Dmand AI links Dr. Colon-Otero to 9 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Fallopian Tube Diseases, Fallopian Tube Neoplasms and Anorexia. Mayo Clinic sponsors the most, 7.

CMS Open Payments shows 12 general payments to Dr. Colon-Otero from 8 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 88% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,962.

Dmand AI lists 10 awards for Dr. Colon-Otero, most recently Mayo Clinic School of CPD Course Director of the Year Award in 2015.

Dr. Colon-Otero graduated from University of Puerto Rico, Medical Sciences Campus in 1979. Dr. Colon-Otero is a member of AOA, ACP, ASCO and ASH.

Dr. Colon-Otero is in network with 9 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. POS plans come from the most carriers, 5. Check the plan with the practice before a visit.